Meeting Highlights from ENDO 2018: 100th Endocrine Society Annual Meeting

March 17-20, 2018
McCormick Place West Chicago, IL

More than 7,500 clinicians, surgeons, pharmacologists, nurse practitioners, pathologists, physician assistants, and allied health professionals arrived from all over the world to gain firsthand knowledge of the latest advances in the diagnosis and management of thyroid diseases, diabetes, obesity, hormone dysregulation, androgen disorders, polycystic ovary syndrome, osteoporosis, transgender care, sex steroids, and many more related topics.

Challenging standards of care for adrenal dysfunction, thyroid cancer, hormonal changes, and PCOS.

In addition to the comprehensive, continuing medical education program spanning  four very full days, three opportunities for in-depth specialty focused programming was available on March 16:

  • A pre-conference event: Managing Cardiometabolic Risk: Practical Considerations and Emerging Approaches, and two day-long satellite programs:
  • American Thyroid Association Symposium: The Spectrum of Thyroid Cancer from surveillance to Systemic Therapies, focused on differentiated thyroid cancer
  • Androgen Excess and PCOS Update on fetal programming, genetics, and emerging insights into the role of antimullerian hormone and adiposity on polycystic ovary syndrome.

While the "gold standard" for management of primary aldosteronism, according to the most recent clinical practice guidelines, is adrenal venous sampling (AVS), findings from the Spartacus trial raises questions given the challenges of cost and practicality in implementing a procedure that requires a high level of experience and skill across the country.

Exploring the place for AVS as the treatment of choice for patients with primary aldosteronism, William Young, Jr., MD, MSc, professor of medicine and chair of the division of endocrinology at the Mayo Clinic College of Medicine in Rochester, Minnesota, argued in favor of the procedure almost always, while Paul Michael Stewart, MD, FRCP, professor, and dean of the University of Leeds medical school, UK, made a case against reliance on AVS in most circumstances. Let the debate begin!

In a second face-off—two leading diabetes experts, Silvio E. Inzucchi, MD, professor of medicine, clinical director for the section of endocrinology, and medical director of the Yale Diabetes Center at Yale School of Medicine in New Haven, Connecticut, and Carol H. Wysham, MD, clinical associate professor of medicine, at the University of Washington-School of Medicine (Seattle), and section head at Rockwood Center for Diabetes and Endocrinology, in Spokane, Washington—debated the continued reliance on treating patients with type 2 diabetes using the standard step-wise approach versus inital combination therapy. The conclusion, with an exclusive video interview, is well timed given the increasing prevalence of diabetes and growing demand for efficacious treatment.

Despite the acknowledged disinterest in weight management among endocrinologists who are not obesity specialists, a call to make this disease a  clinical priority is growing. An impassioned session on the need for a better more engaged approached to helping patients address being overweight was offered by the president of The Obesity Society, Caroline Apovian, MD, professor of medicine and pediatrics at Boston University School of Medicine, and director of the Center for Nutrition and Weight Management at Boston Medical Center, in Massachusetts. Holly Wyatt, MD, associate professor of medicine at the University of Colorado School of Medicine in Aurora, Colorado,  among others.

And finally, EndocrineWeb provides a selection of exclusive video interviews, featuring several award-winning posters and select presentations, on topics ranging from androgens in PCOS and hormone management of disordered eating to treatment of bone Mets in prostate cancer and advancing transgender care in medical school curricula, and more.

 

Last updated on
First Article From This Meeting:
AVS Good for All Patients with Primary Aldosteronism Debatable
close X
SHOW MAIN MENU
SHOW SUB MENU